Sign In
Buy INO
$1.14
-0.0700 (-5.79%)
At Close: Jun 03, 2026
Biotech Bonanza - Second Half Outlook
08:24am, Tuesday, 28'th Jul 2020
Biotech is one of the rare industries whose prospects have improved as the year has progressed. A low interest rate environment, a less hostile regulatory environment, and strong investor interest cre
Better Coronavirus Stock: Inovio vs. Vaxart
07:02am, Tuesday, 28'th Jul 2020
Two biotechs with promising COVID-19 vaccine candidates. But one is the clear winner right now.
So far Monday, July 27, NASDAQ is up 2.28% and the S&P is up 0.89%. Here are this morning’s most
Inovio Is Too Risky for the Average Investor
01:08pm, Monday, 27'th Jul 2020
With the likelihood of a coronavirus vaccine still largely unknown, betting on INO stock based on its vaccine candidate is too risky.
The post Inovio Is Too Risky for the Average Investor appeared fir
Here's Your Guide to the Coronavirus Vaccine Leaders
02:33pm, Sunday, 26'th Jul 2020
Let's take a look at what's happened so far and what's on the horizon.
Should Inovio Pharmaceuticals Be Your Next Coronavirus Buy?
08:08am, Saturday, 25'th Jul 2020
Inovio is making headlines with its coronavirus vaccine candidate. Investors have been reaping the rewards.
Why Moderna, Vaxart, Inovio, and BioNTech Stocks Dropped Today
07:31pm, Friday, 24'th Jul 2020
COVID-19 vaccines might not be the moneymakers investors are hoping for.
The Further It Lags in the Vaccine Race, the Riskier Inovio Stock Looks
08:49am, Friday, 24'th Jul 2020
Inovio Pharmaceuticals (NASDAQ:INO) is a contender in the hyper-competitive field to develop a novel coronavirus vaccine, but with the company falling behind rivals, INO stock is risky. Source: Ascann
Cramer: Here are stocks that stand out in crowded race for a coronavirus vaccine
11:26pm, Thursday, 23'rd Jul 2020
CNBC's Jim Cramer said Thursday that Johnson & Johnson has the most promising stock of the companies that are developing a vaccine to prevent Covid-19.
History and Competition Suggest Caution Toward Inovio Stock
06:31am, Thursday, 23'rd Jul 2020
INO stock has rallied more than 700% so far this year. But the company needs to succeed where it has failed in the past and beat rivals in the process.
9 Stocks to Buy This Week as the Coronavirus Worsens
02:58pm, Wednesday, 22'nd Jul 2020
With the pandemic rearing its ugly head again, these nine companies should give you significant growth potential.
9 Stocks to Buy for the Second Coronavirus Wave
10:58am, Wednesday, 22'nd Jul 2020
With rising coronavirus hospitalizations dominating headlines, investors will shift back toward a pandemic mentality. Here are nine stocks to buy this week to capitalize on this trend.
Kamada: Under-The-Radar COVID-19 Therapy Play With Downside Protection And Margin Of Safety
10:51am, Wednesday, 22'nd Jul 2020
US and global pharma companies that are working on credible COVID-19 treatments are up massively YTD, often more than 100% and far surpassing performance of general pharma indices.
4 Catalysts Could Drive Inovio Pharmaceuticals Stock to Near-term Highs
09:16am, Wednesday, 22'nd Jul 2020
Inovio Pharmaceuticals remains one of the most undervalued of the vaccine makers. Even after a 455% run higher, INO stock has plenty of upside fueled by plenty of catalysts.
The Curtain Is Coming Down on Inovio Pharmaceuticals’ Vaccine Candidate
08:27am, Wednesday, 22'nd Jul 2020
As multiple companies advance vaccine candidates into late-stage clinical trials, INO stock is losing momentum. Is this the end or just a pause?
